Patents by Inventor Jillian Frances Evans

Jillian Frances Evans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of a lysyl oxidase-like 2 inhibitor
    Patent number: 11793797
    Abstract: Described herein is the use of a LOXL2 inhibitor in the treatment or prevention of conditions, diseases, or disorders associated with LOXL2 activity.
    Type: Grant
    Filed: September 6, 2017
    Date of Patent: October 24, 2023
    Assignee: PHARMAKEA, INC.
    Inventors: Gretchen Bain, Jillian Frances Evans, Deidre A. Mackenna, John Howard Hutchinson
  • USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR
    Publication number: 20210177820
    Abstract: Described herein is the use of a LOXL2 inhibitor in the treatment or prevention of conditions, diseases, or disorders associated with LOXL2 activity.
    Type: Application
    Filed: February 3, 2021
    Publication date: June 17, 2021
    Inventors: Gretchen BAIN, Jillian Frances EVANS, Deidre A. MACKENNA, John Howard HUTCHINSON
  • AUTOTAXIN INHIBITORS AND USES THEREOF
    Publication number: 20200215034
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Application
    Filed: March 17, 2020
    Publication date: July 9, 2020
    Inventors: Gretchen BAIN, Jillian Frances EVANS, John Howard HUTCHINSON, David LONERGAN
  • Autotaxin inhibitors and uses thereof
    Patent number: 10632104
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Grant
    Filed: May 24, 2016
    Date of Patent: April 28, 2020
    Assignee: SABRE THERAPEUTICS LLC
    Inventors: Gretchen Bain, Jillian Frances Evans, John Howard Hutchinson, David Lonergan
  • CHEMICAL PROBES OF LYSYL OXIDASK-LIKE 2 AND USES THEREOF
    Publication number: 20190192697
    Abstract: Described herein are probe compounds that interact with the LOXL2 receptor, methods of making such probe compounds, and methods of using such probe compounds in vitro and in vivo.
    Type: Application
    Filed: September 6, 2017
    Publication date: June 27, 2019
    Inventors: Martin W. ROWBOTTOM, John Howard HUTCHINSON, Jillian Frances EVANS, Gretchen BAIN
  • USES OF A LYSYL OXIDASE-LIKE 2 INHIBITOR
    Publication number: 20190192495
    Abstract: Described herein is the use of a LOXL2 inhibitor in the treatment or prevention of conditions, diseases, or disorders associated with LOXL2 activity.
    Type: Application
    Filed: September 6, 2017
    Publication date: June 27, 2019
    Inventors: Gretchen BAIN, Jillian Frances EVANS, Deidre A. MACKENNA, John Howard HUTCHINSON
  • AUTOTAXIN INHIBITORS AND USES THEREOF
    Publication number: 20180147185
    Abstract: Described herein are methods and compositions for the treatment of conditions, diseases, or disorders associated with autotaxin activity. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Application
    Filed: May 24, 2016
    Publication date: May 31, 2018
    Applicant: PharmAkea, Inc.
    Inventors: Gretchen BAIN, Jillian Frances EVANS, John Howard HUTCHINSON, David LONERGAN
  • Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
    Patent number: 9051320
    Abstract: Described herein are methods and compositions for treatment or prevention of metabolic disorder(s) in an individual. The methods and compositions disclosed herein include the use of at least one autotaxin inhibitor compound.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: June 9, 2015
    Assignee: PHARMAKEA, INC.
    Inventor: Jillian Frances Evans